MEDX logo

medmix AG Stock Price

SWX:MEDX Community·CHF 460.4m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

MEDX Share Price Performance

CHF 11.28
-2.08 (-15.57%)
CHF 17.50
Fair Value
CHF 11.28
-2.08 (-15.57%)
35.5% undervalued intrinsic discount
CHF 17.50
Fair Value
Price CHF 11.28
AnalystConsensusTarget CHF 17.50
AnalystLowTarget CHF 14.50
AnalystHighTarget CHF 20.00

MEDX Community Narratives

AnalystConsensusTarget·
Fair Value CHF 17.5 35.5% undervalued intrinsic discount

Advanced Dental And Surgical Launches Will Expand Global Markets

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystLowTarget·
Fair Value CHF 14.5 22.2% undervalued intrinsic discount

Tariff Risks And Execution Challenges Will Pressure Healthcare Devices Before Long-Term Trends Improve

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value CHF 20 43.6% undervalued intrinsic discount

Long-Term Procedure Growth And Cost Efficiencies Will Transform Earnings Power

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 20
43.6% undervalued intrinsic discount
Revenue
5.84% p.a.
Profit Margin
11.25%
Future PE
15.6x
Price in 2029
CHF 23.86
CHF 14.5
22.2% undervalued intrinsic discount
Revenue
3.6% p.a.
Profit Margin
5.56%
Future PE
24.51x
Price in 2028
CHF 17.33

Trending Discussion

Updated Narratives

MEDX logo

MEDX: Stable Long Term Assumptions Will Support Future Upside Potential

Fair Value: CHF 17.5 35.5% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MEDX logo

Long-Term Procedure Growth And Cost Efficiencies Will Transform Earnings Power

Fair Value: CHF 20 43.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MEDX logo

Tariff Risks And Execution Challenges Will Pressure Healthcare Devices Before Long-Term Trends Improve

Fair Value: CHF 14.5 22.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with reasonable growth potential.

1 Risk
3 Rewards

medmix AG Key Details

CHF 468.1m

Revenue

CHF 306.5m

Cost of Revenue

CHF 161.6m

Gross Profit

CHF 167.4m

Other Expenses

-CHF 5.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 26, 2026
-0.14
34.52%
-1.24%
57.9%
View Full Analysis

About MEDX

Founded
1922
Employees
2667
CEO
n/a
WebsiteView website
www.medmix.swiss

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and general industrial industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.

Recent MEDX News & Updates

Recent updates

No updates